MegaMD Co (133750.KQ) Stock Price

MegaMD Co Price

CLOSED
1,515.00KRW+49.00 (+3.29 %)
Market closed

Revenue at MegaMD Co has contracted by 2.6% per year over the past 13 years to 34.59 B KRW. Earnings per share have declined at 31.4% per year over the last 6 years. For MegaMD Co, the net margin of 8.1% is broadly stable versus 8.4% a few years ago. At today's price the dividend yield works out to roughly 3.96%. The payout ratio is around 95% of earnings. The stock trades about 17% above its 52-week low.

MegaMD Co stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of MegaMD Co over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how MegaMD Co stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing MegaMD Co's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

MegaMD Co Stock Price History
DateMegaMD Co Price
8/25/20261,515.00 KRW
8/24/20261,466.00 KRW
8/21/20261,470.00 KRW
8/20/20261,457.00 KRW
8/19/20261,457.00 KRW
8/18/20261,458.00 KRW
8/14/20261,460.00 KRW
8/13/20261,447.00 KRW
8/12/20261,415.00 KRW
8/11/20261,467.00 KRW
8/10/20261,394.00 KRW
8/7/20261,366.00 KRW
8/6/20261,361.00 KRW
8/5/20261,348.00 KRW
8/4/20261,328.00 KRW
8/3/20261,339.00 KRW
7/31/20261,326.00 KRW
7/30/20261,302.00 KRW
7/29/20261,323.00 KRW
7/28/20261,347.00 KRW
7/27/20261,310.00 KRW
7/24/20261,328.00 KRW
7/23/20261,311.00 KRW
7/22/20261,325.00 KRW
7/21/20261,326.00 KRW
7/20/20261,334.00 KRW
7/16/20261,345.00 KRW
7/15/20261,345.00 KRW
7/14/20261,345.00 KRW
7/13/20261,296.00 KRW
7/10/20261,311.00 KRW
7/9/20261,316.00 KRW
7/8/20261,386.00 KRW
7/7/20261,400.00 KRW
7/6/20261,417.00 KRW
7/3/20261,413.00 KRW
7/2/20261,403.00 KRW
7/1/20261,403.00 KRW
6/30/20261,393.00 KRW
6/29/20261,364.00 KRW
6/26/20261,325.00 KRW
6/25/20261,402.00 KRW
6/24/20261,401.00 KRW
6/23/20261,389.00 KRW
6/22/20261,415.00 KRW
6/19/20261,446.00 KRW
6/18/20261,500.00 KRW
6/17/20261,537.00 KRW
6/16/20261,530.00 KRW
6/15/20261,529.00 KRW
6/12/20261,499.00 KRW
6/11/20261,462.00 KRW
6/10/20261,432.00 KRW
6/9/20261,419.00 KRW
6/8/20261,381.00 KRW
6/5/20261,464.00 KRW
6/4/20261,432.00 KRW
6/2/20261,396.00 KRW
6/1/20261,406.00 KRW
5/29/20261,511.00 KRW
5/28/20261,539.00 KRW
5/27/20261,564.00 KRW
5/26/20261,658.00 KRW
5/22/20261,674.00 KRW
5/21/20261,674.00 KRW
5/20/20261,658.00 KRW
5/19/20261,716.00 KRW
5/18/20261,718.00 KRW
5/15/20261,717.00 KRW
5/14/20261,728.00 KRW
5/13/20261,715.00 KRW
5/12/20261,715.00 KRW
5/11/20261,740.00 KRW
5/8/20261,804.00 KRW
5/7/20261,815.00 KRW
5/6/20261,830.00 KRW
5/4/20261,864.00 KRW
4/30/20261,872.00 KRW
4/29/20261,895.00 KRW
4/28/20261,890.00 KRW
4/27/20261,872.00 KRW
4/24/20261,865.00 KRW
4/23/20261,870.00 KRW
4/22/20261,864.00 KRW
4/21/20261,870.00 KRW
4/20/20261,880.00 KRW
4/17/20261,878.00 KRW
4/16/20261,879.00 KRW
4/15/20261,881.00 KRW
4/14/20261,866.00 KRW
4/13/20261,864.00 KRW
4/10/20261,830.00 KRW
4/9/20261,808.00 KRW
4/8/20261,812.00 KRW
4/7/20261,784.00 KRW
4/6/20261,786.00 KRW
4/3/20261,795.00 KRW
4/2/20261,780.00 KRW
4/1/20261,815.00 KRW
3/31/20261,785.00 KRW
3/30/20261,852.00 KRW
3/27/20261,869.00 KRW
3/26/20261,846.00 KRW
3/25/20261,892.00 KRW
3/24/20261,876.00 KRW
3/23/20261,856.00 KRW
3/20/20261,881.00 KRW
3/19/20261,859.00 KRW
3/18/20261,878.00 KRW
3/17/20261,890.00 KRW
3/16/20261,881.00 KRW
3/13/20261,872.00 KRW
3/12/20261,839.00 KRW
3/11/20261,875.00 KRW
3/10/20261,866.00 KRW
3/9/20261,835.00 KRW
3/6/20261,835.00 KRW
3/5/20261,795.00 KRW
2/26/20261,923.00 KRW
2/25/20261,939.00 KRW
2/24/20261,933.00 KRW
2/23/20261,916.00 KRW
2/20/20261,916.00 KRW
2/19/20261,923.00 KRW
2/13/20261,925.00 KRW
2/12/20261,912.00 KRW
2/11/20261,932.00 KRW
2/10/20261,902.00 KRW
2/9/20261,902.00 KRW
2/6/20261,901.00 KRW
2/5/20261,927.00 KRW
2/4/20261,887.00 KRW
2/3/20261,828.00 KRW
2/2/20261,836.00 KRW
1/30/20261,856.00 KRW
1/29/20261,853.00 KRW
1/28/20261,850.00 KRW
1/27/20261,804.00 KRW
1/26/20261,804.00 KRW
1/23/20261,784.00 KRW
1/22/20261,736.00 KRW
1/21/20261,736.00 KRW
1/20/20261,749.00 KRW
1/19/20261,744.00 KRW
1/16/20261,755.00 KRW
1/15/20261,757.00 KRW
1/14/20261,749.00 KRW
1/13/20261,745.00 KRW
1/12/20261,734.00 KRW
1/9/20261,745.00 KRW
1/8/20261,763.00 KRW
1/7/20261,787.00 KRW
1/6/20261,801.00 KRW
1/5/20261,801.00 KRW
1/2/20261,809.00 KRW
12/30/20251,815.00 KRW
12/29/20251,815.00 KRW
12/26/20251,825.00 KRW
12/24/20251,829.00 KRW
12/23/20251,834.00 KRW
12/22/20251,838.00 KRW
12/19/20251,830.00 KRW
12/18/20251,822.00 KRW
12/17/20251,824.00 KRW
12/16/20251,811.00 KRW
12/12/20251,826.00 KRW
12/11/20251,821.00 KRW
12/10/20251,821.00 KRW
12/9/20251,822.00 KRW
12/8/20251,820.00 KRW
12/5/20251,813.00 KRW
12/4/20251,819.00 KRW
12/3/20251,819.00 KRW
12/2/20251,820.00 KRW
12/1/20251,811.00 KRW
11/28/20251,814.00 KRW
11/27/20251,797.00 KRW
11/26/20251,789.00 KRW
11/25/20251,794.00 KRW
11/24/20251,811.00 KRW
11/21/20251,811.00 KRW
11/20/20251,822.00 KRW
11/19/20251,807.00 KRW
11/18/20251,827.00 KRW
11/17/20251,857.00 KRW
11/14/20251,869.00 KRW
11/13/20251,877.00 KRW
11/12/20251,895.00 KRW
11/11/20251,839.00 KRW
11/10/20251,848.00 KRW
11/7/20251,834.00 KRW
11/6/20251,852.00 KRW
11/5/20251,799.00 KRW
11/4/20251,821.00 KRW
11/3/20251,796.00 KRW
10/31/20251,819.00 KRW
10/30/20251,845.00 KRW
10/29/20251,874.00 KRW
10/28/20251,879.00 KRW
10/27/20251,887.00 KRW
10/24/20251,895.00 KRW
10/23/20251,905.00 KRW
10/22/20251,904.00 KRW
10/21/20251,900.00 KRW
10/20/20251,913.00 KRW
10/17/20251,910.00 KRW
10/16/20251,925.00 KRW
10/15/20251,939.00 KRW
10/14/20251,936.00 KRW
10/13/20251,942.00 KRW
10/10/20251,942.00 KRW
10/2/20251,965.00 KRW
10/1/20251,950.00 KRW
9/30/20251,946.00 KRW
9/29/20251,954.00 KRW
9/26/20251,954.00 KRW
9/25/20251,936.00 KRW
9/24/20251,929.00 KRW
9/23/20251,990.00 KRW
9/22/20251,992.00 KRW
9/19/20251,998.00 KRW
9/18/20252,005.00 KRW
9/17/20251,998.00 KRW
9/16/20251,996.00 KRW
9/15/20251,997.00 KRW
9/12/20251,996.00 KRW
9/11/20252,005.00 KRW
9/10/20252,005.00 KRW
9/9/20251,995.00 KRW
9/8/20252,000.00 KRW
9/5/20252,000.00 KRW
9/4/20251,995.00 KRW
9/3/20251,999.00 KRW
9/2/20251,999.00 KRW
9/1/20251,966.00 KRW
8/29/20251,985.00 KRW
8/28/20251,993.00 KRW
8/27/20252,000.00 KRW
Access this data via the Eulerpool API
Get Free API Key

MegaMD Co Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
75.33 B KRW
1.53 B KRW
1.11 B KRW
Jan 1, 2019
80.37 B KRW
-844.58 M KRW
413.24 M KRW
Jan 1, 2020
82.44 B KRW
6.25 B KRW
4.90 B KRW
Jan 1, 2021
79.43 B KRW
4.81 B KRW
6.65 B KRW
Jan 1, 2022
64.47 B KRW
1.87 B KRW
2.11 B KRW
Jan 1, 2023
36.04 B KRW
-5.23 B KRW
-3.20 B KRW
Jan 1, 2024
36.49 B KRW
2.11 B KRW
3.78 B KRW
Jan 1, 2025
34.59 B KRW
1.89 B KRW
2.79 B KRW

MegaMD Co Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 26, 2026, 11:50 AM
 
REVENUEB KRW
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB KRW
EBITB KRW
EBIT MARGIN%
NET INCOMEB KRW
NET INCOME GROWTH%
DIV.KRW
DIV. GROWTH%
SHARESM
20122013201420152016201720182019202020212022202320242025
48.9261.7464.8266.9460.0869.2075.3380.3782.4479.4364.4736.0436.4934.59
–26.204.993.26-10.2515.198.856.702.57-3.65-18.84-44.091.25-5.21
63.9162.7763.0164.6962.6458.4662.8260.4761.6461.5560.5055.5959.8959.45
31.2638.7540.8543.3037.6340.4547.3248.6050.8148.8939.0020.0321.8520.56
10.099.527.1310.262.09-2.111.53-0.846.254.811.87-5.232.111.89
20.6315.4211.0015.333.47-3.052.03-1.057.596.062.89-14.525.775.47
8.128.664.458.761.88-2.821.110.414.906.652.11-3.203.782.79
–6.59-48.6596.96-78.58-250.05-139.40-62.761,085.7135.80-68.24-251.37-218.33-26.28
––––100.0050.0050.0050.00100.00150.00150.00–60.00–
–––––-50.00––100.0050.00––––
16.0016.0021.0421.0421.0421.0421.0421.0421.0421.0421.0421.0421.0421.04
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales MegaMD Co generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue MegaMD Co retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare MegaMD Co's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares MegaMD Co has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against MegaMD Co's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

MegaMD Co stock margins

The MegaMD Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of MegaMD Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for MegaMD Co.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
62.82 %
2.03 %
1.47 %
Jan 1, 2019
60.47 %
-1.05 %
0.51 %
Jan 1, 2020
61.64 %
7.59 %
5.94 %
Jan 1, 2021
61.55 %
6.06 %
8.37 %
Jan 1, 2022
60.50 %
2.90 %
3.28 %
Jan 1, 2023
55.59 %
-14.52 %
-8.87 %
Jan 1, 2024
59.89 %
5.77 %
10.37 %
Jan 1, 2025
59.45 %
5.47 %
8.07 %

MegaMD Co Stock Revenue, EBIT, Earnings per Share

The MegaMD Co earnings per share therefore indicates how much revenue MegaMD Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
3,580.81 KRW
72.83 KRW
52.75 KRW
Jan 1, 2019
0.00 KRW
0.00 KRW
0.00 KRW
Jan 1, 2020
0.00 KRW
0.00 KRW
0.00 KRW
Jan 1, 2021
0.00 KRW
0.00 KRW
0.00 KRW
Jan 1, 2022
0.00 KRW
0.00 KRW
0.00 KRW
Jan 1, 2023
0.00 KRW
0.00 KRW
0.00 KRW
Jan 1, 2024
0.00 KRW
0.00 KRW
0.00 KRW
Jan 1, 2025
0.00 KRW
0.00 KRW
0.00 KRW

MegaMD Co business model & stock analysis

MegaMD Co Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

MegaMD Co historical P/E ratio, EBIT multiple, and P/S ratio

MegaMD Co annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

MegaMD Co shares outstanding

The number of shares of MegaMD Co was 21.04 M in 2025. This indicates how many shares MegaMD Co is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
21.04 M Stocks
Jan 1, 2019
21.04 M Stocks
Jan 1, 2020
21.04 M Stocks
Jan 1, 2021
21.04 M Stocks
Jan 1, 2022
21.04 M Stocks
Jan 1, 2023
21.04 M Stocks
Jan 1, 2024
21.04 M Stocks
Jan 1, 2025
21.04 M Stocks

MegaMD Co Dividend History

8 years of dividend payments

YearAnnual DividendYoY ChangePayments
202460.00KRW↓ 60.0%1×
2022150.00KRW 0.0%—
2021150.00KRW↑ 50.0%1×
2020100.00KRW↑ 100.0%1×
201950.00KRW 0.0%1×
201850.00KRW 0.0%1×
201750.00KRW↓ 50.0%1×
2016100.00KRW—1×

MegaMD Co dividend payout ratio

In 2025, MegaMD Co had a payout ratio of 94.79%. The payout ratio indicates the percentage of the company's profits that MegaMD Co distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2018
94.79 %
Jan 1, 2019
94.79 %
Jan 1, 2020
94.79 %
Jan 1, 2021
94.79 %
Jan 1, 2022
94.79 %
Jan 1, 2023
94.79 %
Jan 1, 2024
94.79 %
Jan 1, 2025
94.79 %
Price targets and forecasts for MegaMD Co are not yet available.

MegaMD Co shareholder structure

% Name
45.74935%
Mega Study Co., Ltd.
Mega Study Co., Ltd.
0.35597%
Son (Ju Eun)
Son (Ju Eun)
0.04448%
Son (Eun Jin)
Son (Eun Jin)
0.00453%
Kim (Jeong Eun)
Kim (Jeong Eun)

MegaMD Co Executives and Management Board

8 members · avg. age 56 · 25 % women

Management

YY

Mr. Yong Guk Yoon (50)

Chief Executive Officer, Director

–
JK

Ms. Jeong Eun Kim (50)

Assistant Managing Director

–
CL

Mr. Cheol Wung Lee (52)

Assistant Managing Director

–
YY

Mr. Yong Hae Ye (55)

Internal Auditor

–

Board of Directors

JS

Mr. Ju Eun Son (63)

Chairman

–
ES

Ms. Eun Jin Son (52)

Director

–
BK

Mr. Bong Seok Kim (62)

Non-Executive Independent Director

–
SL

Mr. Sang Gi Lee (66)

Non-Executive Independent Director

–

MegaMD Co Supply Chain

MegaMD Co Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
1 companies
#NameTrend
1
Megastudy
Supplier·Customer·Diversified Consumer Services·KR
0.82
0.96
0.89
0.83
0.87
0.74

Frequently asked questions about MegaMD Co

Converted at the current exchange rate, the MegaMD Co share trades at 0.94 EUR (1,515.00 KRW).

No history available for MegaMD Co.

The revenue cannot currently be calculated for MegaMD Co.

The profit cannot currently be calculated for MegaMD Co.

The P/E ratio cannot be calculated for MegaMD Co at the moment.

The P/S cannot be calculated for MegaMD Co currently.

The Eulerpool Quality Score for MegaMD Co is 1/10.

The ISIN of MegaMD Co is KR7133750000. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of MegaMD Co is 133750.KQ. The ticker symbol is used to trade MegaMD Co shares on the stock exchange.

Over the past 12 months, MegaMD Co paid a dividend of 60.00 KRW . This corresponds to a dividend yield of about 3.96 %. For the coming 12 months, MegaMD Co is expected to pay a dividend of 60.00 KRW.

The current dividend yield of MegaMD Co is 3.96 %.

MegaMD Co pays a dividend, distributed in the months of , , , .

MegaMD Co paid dividends every year for the past 0 years.

For the upcoming 12 months, dividends amounting to 60.00 KRW are expected. This corresponds to a dividend yield of 3.96 %.

MegaMD Co is assigned to the 'Cyclical consumption' sector.

To receive the latest dividend of MegaMD Co from amounting to 60 KRW, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

The dividends of MegaMD Co are distributed in KRW.

All fundamentals and in-depth analysis of MegaMD Co

Our stock analysis for MegaMD Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of MegaMD Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

MegaMD Co Stock
MegaMD Co Revenue→
MegaMD Co Stock
MegaMD Co Net Income→
MegaMD Co Stock
MegaMD Co P/E→
MegaMD Co Stock
MegaMD Co P/S→
MegaMD Co Stock
MegaMD Co EBIT→
MegaMD Co Stock
MegaMD Co Dividend→
MegaMD Co Stock
MegaMD Co Directors Dealings→
MegaMD Co Stock
MegaMD Co Stocks→
MegaMD Co Stock
MegaMD Co Market capitalization→
MegaMD Co Stock
MegaMD Co Debt→
MegaMD Co Stock
MegaMD Co Liabilities→
MegaMD Co Stock
MegaMD Co Equity→
MegaMD Co Stock
MegaMD Co AAQS→
MegaMD Co Stock
MegaMD Co Employees→
MegaMD Co Stock
MegaMD Co ROE→
MegaMD Co Stock
MegaMD Co ROA→
MegaMD Co Stock
MegaMD Co ROCE→
MegaMD Co Stock
MegaMD Co News→
MegaMD Co Stock
MegaMD Co Analyst Price Targets→

Cyclical consumption Stocks

MegaStudyEdu CoMega Study CoMeGroupMega Perintis Tbk PTMeiko Network Japan CoMedX HoldingsMeiloon Industrial CoMedia Do CoMeituanME Group InternationalMeiwa Estate CoMe 2 On CoAll Stocks A–Z →